SB
Sangeeta Bishnoi
About Sangeeta Bishnoi
Data last updated:
Sangeeta Bishnoi is a Director at Shivalik Rasayan Limited (since 2019) and Director at Medicamen Biotech Limited (since 2019). The companies operate in Agriculture and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹489 Cr; the largest is Shivalik Rasayan Limited at ₹320 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shivalik Rasayan Limited L24237UR1979PLC005041 | Director | 11 Feb 2019 | 1979 | ₹320 Cr (FY 2025) | Active |
 Medicamen Biotech Limited L74899DL1993PLC056594 | Director | 11 Feb 2019 | 1993 | ₹169 Cr (FY 2025) | Active |
Board colleagues of Sangeeta Bishnoi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sangeeta Bishnoi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sangeeta Bishnoi
Sangeeta Bishnoi currently holds 2 directorships: Shivalik Rasayan Limited (Director, since 11 Feb 2019, revenue ₹320 Cr (FY 2025)); Medicamen Biotech Limited (Director, since 11 Feb 2019, revenue ₹169 Cr (FY 2025)).
Sangeeta Bishnoi was first appointed on 11 Feb 2019 as Director at Shivalik Rasayan Limited.
The 2 current companies of Sangeeta Bishnoi that report revenue have a combined latest revenue of ₹489 Cr: Shivalik Rasayan Limited ₹320 Cr (FY 2025); Medicamen Biotech Limited ₹169 Cr (FY 2025).
The current boards of Sangeeta Bishnoi's companies include Ashwani Kumar Sharma (Shivalik Rasayan Limited), Parul Choudhary (Shivalik Rasayan Limited), Rahul Bishnoi (Shivalik Rasayan Limited), Ramit Madan (Shivalik Rasayan Limited), Ravi Kumar Bansal (Shivalik Rasayan Limited), Shaival Saurabh (Shivalik Rasayan Limited), among others.